ArticleOncotarget2017

Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.

Fabian Dominik Mairinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.